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Abstract The aim of the present study was to investigate
the effect of DSP4-induced noradrenaline depletion on
learning and memory in a spatial memory paradigm
(holeboard). Since Harro et al. Brain Res 976:209–216
(2003) have demonstrated that short-term effects of DSP4
administration include both noradrenaline depletion and
changes in dopamine and its metabolites—with the latter
vanishing within 4 weeks after the neurotoxic lesion—the
behavioural effects observed immediately after DSP4
administration cannot solely be related to noradrenaline. In
the present study, spatial learning, reference memory and
working memory were therefore assessed 5–10 weeks after
DSP4 administration. Our results suggest that the admin-
istration of DSP4 did not lead to changes in spatial learning
and memory when behavioural assessment was performed
after a minimum of 5 weeks following DSP4. This lack of
changes in spatial behaviour suggests that the role of nor-
adrenaline regarding these functions may be limited. Future
studies will therefore have to take into account the time-
course of neurotransmitter alterations and behavioural
changes following DSP4 administration.
Keywords Spatial memory  Reference memory 
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Introduction
Attention deﬁcit hyperactivity disorder (ADHD) is one of
the most common psychiatric disorders of childhood and
adolescence and is characterised by the core symptoms
hyperactivity, inattentiveness, impulsivity and distractibil-
ity; other cognitive impairments (Barkley 2006; Biederman
and Faraone 2005; Heal et al. 2008; Lange et al. 2007,
2010; Tucha and Lange 2001; Tucha et al. 2006, 2008)
including spatial working memory (e.g. Mills et al. 2012;
Myatchin et al. 2012) may also occur. This complex
behavioural and cognitive disorder affects approximately
2–7 % of children and adolescents and persists into
adulthood in about 50 % of cases (Barkley 2006;D o ¨pfner
1999). In childhood, ADHD occurs approximately three
times more commonly in boys than girls (Barkley 2006;
Biederman and Faraone 2005; Biederman et al. 1994; Heal
et al. 2008), while the male-to-female ratio is about equal
in adults (Biederman et al. 1994).
Genetic, neurobiological, social and environmental
aspects have been discussed as to the aetiology and path-
ogenesis of ADHD (Barkley 2006; Biederman et al. 1992,
1995;D o ¨pfner 1999). However, these approaches are still
unable to sufﬁciently explain the aetiology of ADHD. A
dysregulation of catecholaminergic neurotransmission in
prefrontal cortex and its connections to striatal areas has
been proposed as a major neurobiological factor (Arnsten
and Dudley 2005; Heal et al. 2008; Russell et al. 2005), and
the characteristic deﬁciency observed in ADHD has been
discussed as a dysfunction of the frontostriatal system
(Davids et al. 2003; Sontag et al. 2008, 2010). Dysfunc-
tional noradrenergic and dopaminergic neurotransmission
appears to be important since psychostimulants such as
methylphenidate, a dopamine and noradrenaline transporter
blocker, have been shown to be effective in the treatment
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ADHD Atten Def Hyp Disord (2012) 4:93–99
DOI 10.1007/s12402-012-0076-4for ADHD (Arnsten 2011). Although the speciﬁc role of
dopamine and noradrenaline is as yet unclear, recent
ﬁndings indicate a dysbalance between these neurotrans-
mitters (Arnsten 2011; Heal et al. 2008).
Three dopaminergic systems have been suggested to
play an important role in ADHD, that is, the mesolimbic,
mesocortical and nigrostriatal pathways (for detail see
Russell et al. 2005). It has been proposed that a dysfunction
of dopamine in the inhibitory control of the frontal cortex is
related to attentive problems and cognitive deﬁcits and that
hyperactivity/impulsivity may emerge due to impaired
dopaminergic function in subcortical regions (Clements
et al. 2003; Heal et al. 2008; Swanson et al. 1998).
In addition to a dysfunctional dopaminergic neuro-
transmission in ADHD, there is evidence suggesting that
noradrenergic neurotransmission is also affected in
ADHD (Arnsten 2011;H e a le ta l .2008; Russell et al.
2005). While some authors have suggested low nor-
adrenaline activity in patients with ADHD (Halperin et al.
1997; Heal et al. 2008;O a d e s1987), others have proposed
an increased noradrenaline activity in the prefrontal cor-
t e xo fc h i l d r e nw i t hA D H D( R u s s e l l2002, 2005; Solanto
1998). A role for noradrenaline in learning and memory
has been elusive and controversial (e.g. Murchison et al.
2004).
A noradrenergic depletion induced by a systemic
administration of the neurotoxin N-(2-chloroethyl)-N-
ethyl-2-bromobenzylamine (DSP4) can be used in order to
elucidate the role of noradrenaline in cognitive functions
such as spatial working memory. This approach may also
provide an animal model (e.g. of ADHD) with a central
noradrenergic lesion. This approach allows the selective
destruction of terminals of noradrenergic neurons origi-
nating in the locus coeruleus (Fritschy and Grzanna 1991)
and reduces brain noradrenaline activity in a dose-depen-
dent manner (Cheetham et al. 1996). Cognitive perfor-
mance following the administration of DSP4 has been
studied for various cognitive functions such as working
memory and reference memory (Ohno et al. 1993, 1997;
Sontag et al. 2008, 2011), short-term memory and attention
(Ruotsalainen et al. 1997), discrimination learning (Al
Zahrani et al. 1997) and motor activity (Jones and Hess
2003). However, while some authors observed an impaired
performance in these functions, others were unable to ﬁnd
any signiﬁcant alteration.
Since Harro et al. (2003) have demonstrated that short-
term effects of DSP4 administration include both nor-
adrenaline depletion and changes in dopamine and its
metabolites—with the latter vanishing within 4 weeks after
the neurotoxic lesion—the behavioural effects observed
immediately after DSP4 administration cannot solely be
related to noradrenaline. Previous studies assessing the
behavioural effects of DSP4 were performed one or
2 weeks after DSP4 administration (Al Zahrani et al. 1997;
Ohno et al. 1993,1997; Ruotsalainen et al. 1997; Sontag
et al. 2008, 2011). The aim of the present study was to
investigate the effect of the sole depletion of noradrenaline
on learning and memory in a spatial memory paradigm.
Behavioural assessment of spatial learning, reference
memory and working memory was therefore performed
ﬁve to 10 weeks after DSP4 administration. We have used
a holeboard task where rats are required to ﬁnd hidden food
pellets (Heim et al. 2000).
Methods
Animals and feeding procedure
Forty-eight male Wistar rats (Charles River Laboratories,
Sulzbach, Germany) aged 12 weeks (weight approximately
300 g at the beginning of the experiment) were used. The
animals were kept in standard cages on a 12-h light/12-h
dark cycle (room temperature, 22 C; humidity, 50 %).
The access to food was restricted since the learning para-
digm on the Cogitat holeboard is based on food rein-
forcement (i.e. 45 mg dustless sucrose pellets, Bio-Serv,
Frenchtown, New Jersey, USA). Water was provided
ad libitum. Rats were fed (standard food pellets, Ssniff
Spezialita ¨ten GmbH, Soest, Germany) after the testing
procedures for 1 h a day. The rats’ body weight and general
health were carefully controlled, and a weight reduction of
more than 15 % compared to freely fed rats was avoided in
order to prevent stress and subsequent changes in dopa-
minergic neurotransmission (Bear 1999; Deroche et al.
1995; Pothos et al. 1995).
All experiments were performed in accordance with the
national laws (German law on Protection of Animals) and
the principles of laboratory animal care (NIH publication
No. 86- 23, revised 1985).
The Cogitat holeboard
The learning behaviour of the rats was tested with the
Cogitat holeboard system (Cogitron GmbH, Go ¨ttingen,
Germany). This system consists of a board with 25 holes.
Each hole of the board is closed at its lower end by an
adjustable feeding plate with a depression for a food pellet.
Feeding plate and food pellets are of the same colour. The
ground below the feeding plate is covered with food pel-
lets, in order to prevent the animals from ﬁnding the pattern
of the pellet distribution by using olfactory stimuli. Each
hole is ﬁtted with infrared light beams at different levels of
the hole to measure activity. An interruption of the upper
light beam is deﬁned as an ‘‘inspection’’, while the term
‘‘visits’’ is related to the lower light beam. Finally, there is
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123an infrared beam at the feeding plate measuring the col-
lection of a food pellet. A more detailed description of the
Cogitat holeboard system can be found elsewhere (Heim
et al. 2000). In the present experiment, eight of the 25 holes
were baited. A search trial was automatically ﬁnished when
a rat had found all the hidden pellets or after a ﬁxed period
of 60s.
On the Cogitat holeboard, performance of rats can be
divided in reference memory and working memory.
Reference memory is deﬁned as the ability to remember
the baited pattern and should improve over time. The
focus is therefore on comparisons between trials. By
contrast, working memory is deﬁned as the ability to
remember which holes a rat has already inspected, vis-
ited and/or emptied in one trial. In each single trial, the
following parameters were measured: (1) working
memory error (i.e. the percentage of inspections to pre-
viously baited holes in a single trial in relation to the
total number of holes inspected) and (2) reference
memory error (i.e. the percentage of inspections to
nonbaited holes in relation to the total number of holes
inspected).
DSP4 administration, habituation and testing procedure
The rats were habituated for 10 days to room conditions,
light/dark circle, feeding and other routine procedures.
They were then randomly divided into four groups of 12
rats each. The animals of the control group were injected
with saline; the animals of the other three groups
received an injection of DSP4 (Sigma-Aldrich, Schnell-
dorf, Germany) at a dose of 10, 20 or 50 mg/kg body
weight. DSP4 was dissolved in saline; both DSP4 solu-
tion and saline were administered intraperitoneally. A
5-week period followed the administration of DSP4 or
saline during which body weight and health were
checked once daily and the feeding procedure was less
restrictive. This period also allowed for a recovery of the
peripheral noradrenergic system (Fritschy and Grzanna
1991).
During the recovery period, animals were habituated to
the Cogitat system as follows. Rats were placed on the
holeboard for 5 min once daily for 2 weeks. During this
habituation phase, eight holes were baited with a pellet and
a different pattern was chosen each day in order to ascer-
tain that each hole was baited at least once.
After habituation to the holeboard, the rats were tested
once daily for 5 weeks. In this testing period, a ﬁxed pat-
tern of baited pellets was used. A trial was ﬁnished when
the rat had found all pellets or after a ﬁxed period of 60s.
The order in which the animals were tested during habit-
uation and testing periods was randomised in order to
reduce circadian inﬂuences.
Statistical analysis
Comparisons between the DSP4 groups were made for
each week by avering the results of ﬁve consecutive days.
The statistical analysis of differences between DSP4
groups was carried out using the Mann–Whitney U test
(between-subject design); p values lower than 0.05 were
considered statistically signiﬁcant. With regard to learning
performance within each group, the ﬁrst week of testing
was compared with the following weeks by using the
Wilcoxon test; p values of \0.05 were considered statis-
tically signiﬁcant. All statistical analyses were carried out
using the Statistical Package for Social Sciences 19.0
(SPSS) for Windows.
Results
Reference memory error
Asforspatialreferencememory,theperformanceoftheDSP4
andcontrolgroupsispresentedinFig. 1andTable 1.Mo stof
the comparisons between the DSP4 and saline-treated groups
did not reach statistical signiﬁcance, except the following: in
the second week, the DSP4_10 mg/kg group made signiﬁ-
cantly more reference memory errors than the DSP4_20
mg/kg group (p = 0.046; z =- 1.992). In the fourth week,
the control group made signiﬁcantly more reference memory
errors compared to the DSP4_20 mg/kg group (p = 0.04;
z =- 2.05).
The control group made signiﬁcantly fewer reference
memory errors in week 5 than in week 1 (p = 0.005;
z =- 2.824); the other comparisons were not statistically
signiﬁcant. The DSP4_10 mg/kg animals made signiﬁ-
cantly fewer reference memory errors in the last 2 weeks
than in the ﬁrst week (p = 0.01; z =- 2.589 com-
pared with week 4; p = 0.003; z =- 2.981 in comparison
Fig. 1 Mean percentage of reference memory errors for all groups
over 5 weeks
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tical signiﬁcance. The dose of 20 mg/kg DSP4 caused
signiﬁcantly fewer reference memory errors in week
4( p = 0.034; z =- 2.118) and week 5 (p = 0.004;
z =- 2.903) than in week 1. The rats treated with the
high dose of DSP4 (50 mg/kg) made signiﬁcantly more
reference memory errors in the ﬁrst week than in the
fourth (p = 0.008; z =- 2.667) and ﬁfth (p = 0.002;
z =- 3.059) weeks. The other comparisons were not sta-
tistically signiﬁcant.
Working memory error
With regard to the working memory error, the spatial
learning performance of the DSP4 and control groups is
presented in Fig. 2 (for more detailed data see Table 1).
The administration of 50 mg/kg DSP4 signiﬁcantly
increased the working memory error compared with con-
trol animals (p = 0.046; z =- 1.992). None of the
remaining comparisons between DSP4 groups or the sal-
ine-treated group achieved statistical signiﬁcance.
The animals of the control group made signiﬁcantly
more working memory errors in the ﬁrst week than in
week 3 (p = 0.034; z =- 2.119), week 4 (p = 0.015;
z =- 2.432) and week 5 (p = 0.019; z =- 2.353). The
DSP4_10 mg/kg rats made in the last week only signiﬁ-
cantly fewer working memory errors than in the ﬁrst week
(p = 0.012; z =- 2.51); all other comparisons between
week 1 and the following weeks were not statistically
signiﬁcant. The animals treated with the medium dose of
DSP4 (20 mg/kg) showed signiﬁcantly fewer working
memory errors in the ﬁrst week than in all the following
weeks (compared with week 2: p = 0.008; z =- 2.667;
compared with week 3: p = 0.008; z =- 2.667; compared
with week 4: p = 0.019; z =- 2.353; compared with week
5: p = 0.005; z =- 2.824). Similar to the DSP4_20 mg/kg
group, the DSP4_50 mg/kg group made signiﬁcantly more
working memory errors in the ﬁrst week than in the second
week (p = 0.041; z =- 2.04), the third week (p = 0.002;
z =- 3.059), the fourth week (p = 0.002; z =- 3.059)
and the ﬁfth week (p = 0.004; z =- 2.903).
Discussion
Several previous studies have presented evidence of
impaired cognitive functioning following DSP4 adminis-
tration (Compton et al. 1995; Wenk et al. 1987). However,
some authors were unable to demonstrate any impairments
(Al Zahrani et al. 1997; Benloucif et al. 1995; Langlais
et al. 1993). All previous studies discussed in this paper
share two important aspects, that is, (1) they use a DSP4
dose of 50 mg/kg only and (2) they assume that the treat-
ment with DSP4 affects the noradrenergic system exclu-
sively, independent of the time elapsed following the
administration of DSP4 (Cheetham et al. 1996; Fritschy
and Grzanna 1991). By contrast, Harro et al. (2003) dem-
onstrated that the effect following DSP4 administration
Table 1 Performance on the
Cogitat holeboard of the DSP4
and saline groups for each week
(mean ± standard error)
a Compared with control group,
b compared with DSP4_10
mg/kg,
1 compared with week 1,
a, b, 1: p B 0.05
Control DSP4_10 mg DSP4_20 mg DSP4_50 mg
Reference memory error
Week 1 16.71 ± 2.49 16.15 ± 2.14 14.61 ± 2.64 14.28 ± 1.82
Week 2 12.64 ± 1.27 14.35 ± 1.25 11.71 ± 1.87
b 12.74 ± 2.44
Week 3 18.03 ± 2.4 15.28 ± 1.93 14.02 ± 1.66 16.95 ± 1.94
Week 4 12.45 ± 1.82 8.43 ± 1.69
1 7.73 ± 1.19
a1 8.63 ± 1.5
1
Week 5 6.80 ± 1.35
1 4.20 ± 1.15
1 4.09 ± 1.22
1 4.71 ± 1.22
1
Working memory error
Week 1 11.84 ± 1.06 10.58 ± 2.01 12.54 ± 0.93 14.52 ± 1.2
a
Week 2 10.14 ± 1.48 7.60 ± 0.93 8.04 ± 1.24
1 9.41 ± 1.88
1
Week 3 7.04 ± 1.27
1 7.79 ± 0.94 7.12 ± 1.49
1 7.76 ± 0.74
1
Week 4 6.32 ± 1.02
1 7.47 ± 2.1 7.07 ± 1.48
1 6.15 ± 1.25
1
Week 5 7.11 ± 1.08
1 6.69 ± 1.56
1 4.49 ± 1.01
1 5.49 ± 1.32
1
Fig. 2 Mean percentage of working memory errors for all groups
over 5 weeks
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123changes over time and that the dopaminergic system is also
affected after DSP4 administration. However, the latter
effect appears to be temporary and to vanish within a few
weeks. The aim of the present study was to examine the
exclusive effect of a noradrenergic depletion by DSP4 on
cognitive skills such as learning, reference memory and
working memory in a spatial memory task. Behavioural
testing was therefore performed 5 weeks after DSP4
administration, when dopaminergic effects of DSP4 have
been reported to be greatly diminished (Harro et al. 2003).
All groups showed clear improvements in the Cogitat
holeboard paradigm, that is, the rats of all groups were able
to enhance their performance in spatial learning and
memory over time. In detail, all DSP4 groups and the
control group displayed signiﬁcant improvements in
working memory over the course of 5 weeks. With regard
to reference memory error, all groups displayed a moderate
improvement in the second week followed by an increase
in errors in the third week; the percentage of reference
memory errors of the DSP4_50 mg and control groups
exceeded the values of the previous weeks. In the
remaining weeks, a consistent and statistically signiﬁcant
decline of reference memory error could be observed.
These data suggest that all groups were able to learn the
paradigm and to improve their performance over time, as
shown by a clear reduction in both working memory and
reference memory errors.
Another aim of the present study was to investigate the
effect of central noradrenergic depletion on rats’ perfor-
mance in a spatial memory task as assessed by comparing
various DSP4 doses and a saline-treated group. Taken
together, the present data suggest little difference in the
performance of spatial memory between the DSP4 groups
and the control group. A limitation of the present study is
the lack of histological or neurochemical analyses regard-
ing the central noradrenergic system.
With regard to reference memory error, only two com-
parisons were statistically signiﬁcant (i.e. the comparisons
between DSP4_10 mg/kg and DSP4_20 mg/kg in week 2
and between DSP4_20 mg/kg and controls in week 4).
Over the course of time, the DSP4_50 mg/kg group always
made fewer reference memory errors than the saline-trea-
ted animals. The difference between the medium and low
doses of DSP4 in week 2 as well as the difference in DSP4
between animals that received medium dose and control
animals reached statistical signiﬁcance. Interestingly, the
low dose in the ﬁrst comparison mentioned and the control
group in the latter comparison showed more reference
memory errors than the medium dose or high dose, sug-
gesting a beneﬁcial effect of DSP4. This seems to be
counterintuitive and should be interpreted as an artefact,
not least because there does not appear to be a linear
relationship between DSP4 dose, more precisely the dose-
dependent noradrenergic depletion as suggested by Chee-
tham et al. (1996), and the performance in spatial reference
memory. In summary, our data indicate that the DSP4
administration had a minor effect on reference memory,
which is in accordance with previous ﬁndings (Ohno et al.
1993, 1997).
As to spatial working memory, in the ﬁrst week, the
DSP4_50 mg/kg group made signiﬁcantly more working
memory errors compared to the control group. In sub-
sequent weeks, the DSP4_50 mg/kg animals showed fewer
working memory errors than controls, with the exception of
week 4, where the group treated with the high dose dis-
played slightly more errors. This is in contrast to previous
publications reporting working memory impairments
(Ohno et al. 1993; Sontag et al. 2008). Our data suggest no
linear relationship between noradrenaline depletion
induced by DSP4 and the spatial working memory per-
formance as assessed with the Cogitat holeboard. In the
present experiment, the spatial working memory of rats
was not affected by DSP4 administration. This result is not
in line with previous publications (Ohno et al. 1993; Sontag
et al. 2008) but agrees with other studies that were unable
to reveal an effect of DSP4 on various cognitive functions
(Al Zahrani et al. 1997; Benloucif et al. 1995; Langlais
et al. 1993) including spatial working memory (Sontag
et al. 2011).
In summary, the present study does not support the
notion that noradrenergic depletion following DSP4
administration affects the spatial memory skills of rats in a
holeboard paradigm such as Cogitat. Neither was the
ability to learn a certain pattern affected by DSP4 nor were
there any substantial or systematic differences between the
DSP4 and saline-treated groups with regard to spatial ref-
erence memory and spatial working memory.
Attempts at the explanation of the present ﬁndings will
remain speculative. It is conceivable that the DSP4-induced
noradrenaline depletion is limited over time. However,
there is no support in the literature for a time-limited effect
of DSP4 on noradrenaline, at least not for the high dose
(50 mg/kg) (Harro et al. 2003). On the contrary, the lasting
effect of DSP4 on noradrenergic terminals has been
described as one of the advantages of DSP4 administration
(Cheetham et al. 1996; Fritschy and Grzanna 1991), and
there has been no indication for a time-limited effect (Al
Zahrani et al. 1997; Benloucif et al. 1995; Cheetham et al.
1996; Compton et al. 1995; Fritschy and Grzanna 1991;
Langlais et al. 1993; Ohno et al. 1993; Wenk et al. 1987).
One could also conclude that the paradigm used in the
present experiment (holeboard system) did not test cogni-
tive functions affected by noradrenergic depletion or that
the task was not sensitive enough to reveal existing effects.
However, the following observations do not support this
view. First, there is evidence that working memory is
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123modulated by catecholamines and noradrenaline in partic-
ular (Ohno et al. 1993; Ramos and Arnsten 2007; Sontag
et al. 2008). Second, Sontag et al. (2008), using the Cogitat
holeboard, have shown that noradrenergic depletion by the
administration of DSP4 causes signiﬁcant impairment in
working memory without affecting reference memory. In
contrast to the present study, the authors’ focus was not on
the effect of DSP4 on learning but rather on the effect of
noradrenaline depletion on a task that rats had previously
learnt (Sontag et al. 2008, 2011). In the studies by Sontag
et al. (2008, 2011), rats were trained ﬁrst, then treated with
DSP4 and tested after a 2-week recovery of the peripheral
noradrenaline system, as has been suggested by several
studies using DSP4 (Al Zahrani et al. 1997; Ohno et al.
1993; Ruotsalainen et al. 1997). Harro et al. (2003) have
shown that DSP4 does not solely affect noradrenaline ter-
minals, but dopamine and serotonin levels as well as
dopamine receptor concentrations may also be affected
(Harro et al. 2003). In conclusion, other neurotransmitters
apart from noradrenaline may be directly or indirectly inﬂu-
encedbyDSP4,asmentionedbySontagetal.(2008),andthis
inﬂuence may be time-limited, as suggested by Harro et al.
(2003). This may be an explanation for the differing ﬁndings
of Sontag et al. (2008) and the present study.
Another explanation for the present ﬁndings is that there
may be no direct functional relationship between central
noradrenaline level and spatial memory. Noradrenaline
may not affect spatial memory but rather other more fun-
damental cognitive functions such as attention. However,
there is evidence disagreeing with this viewpoint (see Ohno
et al. 1993; Sontag et al. 2008). In conclusion, the
administration of DSP4 did not lead to changes in spatial
learning and memory when behavioural assessment was
performed 5 weeks after DSP4 administration.
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